New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 7, 2014
07:30 EDTILMNIllumina weakness creates buying opportunity, says Wells Fargo
Wells Fargo believes that the recent decline in Illumina's stock is mostly related to its correlation with biotech indices, and the firm sees this correlation as "a technical rather than a fundamental phenomenon." The firm believes that demand for the company's HiSeq, MiSeq, and HiSeq X instruments are strong, and it now identifies the stock as its top pick in the tools space. It increased its price target on the shares to $170-175 from $155-$160.
News For ILMN From The Last 14 Days
Check below for free stories on ILMN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 24, 2014
07:18 EDTILMNIllumina price target raised to $195 from $180 at Leerink
Leerink raised its price target for Illumina shares to $195 citing continued instrument momentum following the company's Q2 results. The firm keeps an Outperform rating on the stock.
July 23, 2014
16:23 EDTILMNIllumina raises FY14 EPS view to $2.26-$2.28 from $2.10-$2.15, consensus $2.17
Subscribe for More Information
16:19 EDTILMNIllumina reports Q2 EPS 57c, consensus 51c
Subscribe for More Information
15:30 EDTILMNNotable companies reporting after market close
Subscribe for More Information
July 21, 2014
06:32 EDTILMNIllumina's NGS selected by Berry Genomics
Subscribe for More Information
July 17, 2014
10:00 EDTILMNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:20 EDTILMNIllumina initiated with a Buy at Citigroup
Subscribe for More Information
July 16, 2014
06:31 EDTILMNIllumina acquires Myraqa
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use